Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DX24FQQBN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,881
Award facts
- Contract value 100% obligated
- $2,881.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,881.04 contract has a performance period running through May 13, 2024. The order is placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA's Medical Supply Chain division, which supports recurring pharmaceutical and medical supply needs for military health facilities globally. This contract has no set-aside designation.
Quick answers
Who was awarded contract SPE2DX24FQQBN?
SPE2DX24FQQBN was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 10, 2024.
How much is contract SPE2DX24FQQBN worth?
The government has obligated $2,881 on SPE2DX24FQQBN.
Is contract SPE2DX24FQQBN an order under another contract?
Yes. SPE2DX24FQQBN is a delivery order under SPE2DX15D9338, an indefinite delivery contract.
Was contract SPE2DX24FQQBN competed?
The extent of competition for SPE2DX24FQQBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award